Cargando…
Evaluation of the efficacy of HEMO(2)life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial
BACKGROUND: Preventing ischemia‒reperfusion injury (IRI) is a major issue in kidney transplantation, particularly for transplant recipients receiving a kidney from extended criteria donors (ECD). The main consequence of IRI is delayed graft function (DGF). Hypoxia is one of the key factors in IRI, s...
Autores principales: | Le Meur, Yannick, Nowak, Emmanuel, Barrou, Benoit, Thierry, Antoine, Badet, Lionel, Buchler, Matthias, Rerolle, Jean-Philippe, Golbin, Leonard, Duveau, Agnès, Dantal, Jacques, Merville, Pierre, Kamar, Nassim, Demini, Leïla, Zal, Franck |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150461/ https://www.ncbi.nlm.nih.gov/pubmed/37127632 http://dx.doi.org/10.1186/s13063-023-07302-3 |
Ejemplares similares
-
The oxygen carrier M101 alleviates complement activation, which may be beneficial for donor organ preservation
por: Puissant-Lubrano, Bénédicte, et al.
Publicado: (2022) -
Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO(2)Life® (M101)
por: Lupon, Elise, et al.
Publicado: (2021) -
Hemo-dynamics
por: Zamir, Mair
Publicado: (2016) -
Beneficial Effects of Two Marine Oxygen Carriers, M101 and M201, on Human Islet Quality in Hypoxic Culture Conditions
por: Lemaire, Florent, et al.
Publicado: (2023) -
Hemos perdido el reino
por: Campos, Marco Antonio, 1949-
Publicado: (1987)